The study will be submitted for publication.
More Articles on Orthopedic Devices:
Spinal Elements Launches Ti-Bond
Exactech Announces 2Q Revenue of $55.2M, Up 7%
DJO Global 2Q Net Sales Reach $286M, a 2.9% Increasea
TranS1 completed its first head-to-head retrospective study comparing its proprietary AxiaLIF pre-sacral interbody fusion procedure to anterior lumbar interbody fusion.
Two independent spine surgeons evaluated 96 total patients at two year or greater follow up with thin slice CT scans. The combined review of both surgeons demonstrated improved fusion rates with AxiaLIF over ALIF, though the difference in the rates was not statistically significant. Further, the AxiaLIF cohort experienced no serious adverse events, compared with the ALIF cohort, which reported two serious adverse events.
The study will be submitted for publication.
The study will be submitted for publication.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.